Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DISA Vascular (now operating as DISA Medinotec) is a South African medical device company specializing in the design, development, and manufacture of vascular and airway management technologies. Founded in 1998, the company was a pioneer in the African medical device industry, producing the first CE-marked coronary stents in the region, including the SolarFlex and Chromis cobalt-chromium systems. Following its acquisition by the US-based holding company Medinotec Inc. in 2022, the company has expanded its focus to include the Trachealator, a proprietary non-occlusive airway dilation balloon, and various ENT and surgical devices. DISA Vascular operates ISO-certified manufacturing facilities in South Africa and serves international markets through a global distribution network and its affiliate, DISA Life Sciences. The company is currently focused on expanding its presence in the United States and European markets with its niche interventional products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DISA Vascular.